JP2023530154A5 - - Google Patents
Info
- Publication number
- JP2023530154A5 JP2023530154A5 JP2022577503A JP2022577503A JP2023530154A5 JP 2023530154 A5 JP2023530154 A5 JP 2023530154A5 JP 2022577503 A JP2022577503 A JP 2022577503A JP 2022577503 A JP2022577503 A JP 2022577503A JP 2023530154 A5 JP2023530154 A5 JP 2023530154A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- composition according
- flexneri
- glucose
- glycosylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040844P | 2020-06-18 | 2020-06-18 | |
| US63/040,844 | 2020-06-18 | ||
| US202063043883P | 2020-06-25 | 2020-06-25 | |
| EP20182139 | 2020-06-25 | ||
| EP20182138 | 2020-06-25 | ||
| EP20182139.4 | 2020-06-25 | ||
| US63/043,883 | 2020-06-25 | ||
| EP20182138.6 | 2020-06-25 | ||
| PCT/IB2021/055361 WO2021255684A1 (en) | 2020-06-18 | 2021-06-17 | Shigella-tetravalent (shigella4v) bioconjugate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530154A JP2023530154A (ja) | 2023-07-13 |
| JP2023530154A5 true JP2023530154A5 (cg-RX-API-DMAC7.html) | 2024-06-20 |
Family
ID=76502778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577503A Pending JP2023530154A (ja) | 2020-06-18 | 2021-06-17 | 赤痢菌4価(Shigella4V)バイオコンジュゲート |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230346902A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4168040A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023530154A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115697396A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022024294A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3185719A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022016587A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021255684A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026087718A1 (en) * | 2024-10-23 | 2026-04-30 | Institut Pasteur | A multivalent shigella vaccine and methods of making and using thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| DK1481057T3 (da) | 2002-03-07 | 2006-05-15 | Eidgenoess Tech Hochschule | System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært |
| ES2535084T3 (es) | 2005-05-11 | 2015-05-05 | Eth Zurich | Proteínas N-glicosiladas recombinantes procedentes de células procariotas |
| ATE539079T1 (de) | 2006-03-23 | 2012-01-15 | Novartis Ag | Imidazochinoxalinverbindungen als immunmodulatoren |
| CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| US9238830B2 (en) | 2006-12-13 | 2016-01-19 | The Governors Of The University Of Alberta | Methods and systems for O-glycosylating proteins |
| SI2257307T1 (sl) | 2008-02-20 | 2018-09-28 | Glaxosmithkline Biologicals S.A. | Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic |
| CN101569744A (zh) * | 2009-01-20 | 2009-11-04 | 张鑫 | 一种细菌性痢疾多价疫苗 |
| NO2501406T3 (cg-RX-API-DMAC7.html) | 2009-11-19 | 2018-05-19 | ||
| KR20150068998A (ko) * | 2012-10-12 | 2015-06-22 | 글리코박신 아게 | 숙주 세포 변형 방법 |
| EP2917351B1 (en) * | 2012-11-07 | 2018-12-19 | GlaxoSmithKline Biologicals S.A. | Production of recombinant vaccine in e. coli by enzymatic conjugation |
| NZ723328A (en) | 2014-02-24 | 2018-01-26 | Glycovaxyn Ag | Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture |
| CN106659799B (zh) * | 2014-07-25 | 2020-07-17 | 碧奥辛斯有限责任公司 | 用于制备针对因肠致病性细菌引起的感染的广谱疫苗的包含表达内置的多个表位的分子构建体的基本单元的糖缀合物疫苗 |
| CN105695497B (zh) | 2014-11-27 | 2019-09-24 | 中国人民解放军军事医学科学院生物工程研究所 | 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用 |
| CN114796472A (zh) * | 2015-06-16 | 2022-07-29 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| GB201518668D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Immunogenic Comosition |
-
2021
- 2021-06-17 CA CA3185719A patent/CA3185719A1/en active Pending
- 2021-06-17 WO PCT/IB2021/055361 patent/WO2021255684A1/en not_active Ceased
- 2021-06-17 EP EP21733220.4A patent/EP4168040A1/en active Pending
- 2021-06-17 MX MX2022016587A patent/MX2022016587A/es unknown
- 2021-06-17 US US18/001,551 patent/US20230346902A1/en active Pending
- 2021-06-17 CN CN202180043251.6A patent/CN115697396A/zh active Pending
- 2021-06-17 BR BR112022024294A patent/BR112022024294A2/pt unknown
- 2021-06-17 JP JP2022577503A patent/JP2023530154A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7494276B2 (ja) | 非天然アミノ酸とのポリペプチド抗原接合体 | |
| CN106535927B (zh) | 新颖多糖及其用途 | |
| TWI751513B (zh) | E. coli O-抗原多醣生物結合物、其製備方法及其使用方法 | |
| JP7589164B2 (ja) | 大腸菌o抗原多糖のバイオコンジュゲートを製造する方法、その組成物およびその使用方法 | |
| CN102482646B (zh) | 幽门螺杆菌脂多糖外部核心表位 | |
| CN115803087A (zh) | 多价疫苗组合物及其用途 | |
| US12290563B2 (en) | Production of E. coli 018 bioconjugates | |
| Altman et al. | Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1, 6-glucan chain | |
| US20230346902A1 (en) | Shigella-Tetravalent (Shigella4V) Bioconjugate | |
| HK40129496A (en) | Polypeptide-antigen conjugates with non-natural amino acids | |
| JP2025535072A (ja) | モラクセラ科o結合型オリゴ糖転移酵素、糖鎖付加断片、及びそれらの使用 | |
| HK40015413B (en) | Polypeptide-antigen conjugates with non-natural amino acids | |
| HK40015413A (en) | Polypeptide-antigen conjugates with non-natural amino acids |